BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/17/2021 8:43:53 AM | Browse: 406 | Download: 571
 |
Received |
|
2021-04-02 02:11 |
|
Peer-Review Started |
|
2021-04-02 02:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-07 01:28 |
|
Revised |
|
2021-06-14 23:08 |
|
Second Decision |
|
2021-08-31 03:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-31 09:16 |
|
Articles in Press |
|
2021-08-31 09:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-16 05:20 |
|
Publish the Manuscript Online |
|
2021-09-17 08:43 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Metastatic disease to the liver: Locoregional therapy strategies and outcomes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kylie E Zane, Jordan M Cloyd, Khalid S Mumtaz, Vibhor Wadhwa and Mina S Makary |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mina S Makary, MD, Assistant Professor, Attending Doctor, Director, Director, Department of Radiology, The Ohio State University Wexner Medical Center, 4th Floor Faculty Office Tower, Columbus, OH 43210, United States. mina.makary@osumc.edu |
| Key Words |
Metastatic liver cancer; Transarterial embolization; Chemoembolization; Radioembolization; Ablation; Transarterial chemoembolization; Transarterial radioembolization |
| Core Tip |
Locoregional percutaneous catheter-directed approaches have been associated with better tumor response, improved disease-free and overall survival, and decreased morbidity in metastatic disease to the liver compared to standard treatment1. This review explores recent advances in liver-directed therapies for metastatic liver disease from primary colorectal, neuroendocrine, breast, and lung cancer, as well as uveal melanoma, cholangiocarcinoma, and sarcoma. Therapies discussed include bland transarterial embolization, chemoembolization, radioembolization, and ablative therapies, with a focus on current treatment approaches, outcomes of locoregional therapy, and future directions in each type of metastatic disease. |
| Publish Date |
2021-09-17 08:43 |
| Citation |
Zane KE, Cloyd JM, Mumtaz KS, Wadhwa V, Makary MS. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J Clin Oncol 2021; 12(9): 725-745 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i9/725.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i9.725 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
